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Background: The prevalence of left ventricular non-compaction (LVNC) has been estimated at 0.05%. The increasing use of cardiac 
magnetic resonance imaging (CMR) has led to a surge in the reports of LVNC. Those with non-ischemic dilated cardiomyopathy (NIDCM) 
have also been noted to have prominent left ventricular (LV) trabeculations. We evaluated the difference in clinical outcomes in patients 
with NIDCM to those with LVNC as diagnosed by established CMR criteria.
methods: A retrospective study was performed on 71 patients diagnosed with NIDCM who underwent a CMR between 1/1/2012 and 
8/30/2014. Volumetric quantification was performed to obtain chamber size and ejection fraction (EF). The ratio of compacted:non-
compacted myocardium was measured at end-diastole in 4- and 2-chamber views.
results: Of 71 patients, 25% met CMR criteria for LVNC. The incidence of prior stroke, diabetes mellitus, hypertension, end-stage renal 
disease and cancer did not differ between the groups. The mean LVEF in both groups was 36% (p=0.992). There was no statistical 
difference in the mean number of heart failure admissions (p=0.747) or the number of ventricular (p=0.473) or atrial arrhythmias (p=0.204) 
between groups.
conclusion: This is the largest study comparing the clinical outcomes of patients with CMR defined LVNC to those with NIDCM. We 
demonstrate that LVNC may not be prognostically different than NIDCM, suggesting it may be a morphological variant of NIDCM or 
perhaps that the current LVNC CMR criteria need revision.
Patients with ≥ 3 segments with non-compacted:compacted 
ratio ≥ 2.3
n = 18 (%)
Patients with < 3 segments with non-
compacted:compacted ratio < 2.3
n = 53 (%)
p-value
Males 7 (38.9) 32 (60.4)
Mean Age 50.9 +/- 17.9 50.4 +/- 15.3 0.907
Stroke 1 (5.6) 1 (1.9) 0.416
Diabetes Mellitus 4 (22.2) 16 (30.2) 0.516
Hypertension 9 (50) 27 (50.9) 0.945
End-Stage Renal Disease 0 (0) 1 (1.9) 0.557
Cancer 3 (16.7) 7 (13.2) 0.715
Average Number of Heart Failure 
Admissions per Patient 0.83 +/- 1.0 0.73 +/- 1.2 0.747
Thromboembolic Events 2 (11) 3 (5.7) 0.435
Supraventricular Tachycardia 6 (33.3) 10 (18.9) 0.204
Ventricular Tachycardia 2 (11.1) 11 (20.8) 0.473
Left Ventricular Assist Device 1 (5.6) 0 (0) 0.084
ICD 6 (33.3) 10 (18.9) 0.393
Heart Transplantation 0 (0) 0 (0) -
Mortality 0 (0) 1 (1.9) 0.557
LV EF (%) 36.0 +/- 17.9 36.1 +/- 12.7 0.992
LV End Diastolic Volume Index 
(mL/m2) 139.0 +/- 49.0 122.0 +/- 41.4 0.157
LV End Systolic Volume Index 
(mL/m2) 93.8 +/- 53.6 81.9 +/- 41.6 0.333
LV Mass Index (g/m2) 58.9 +/- 19.5 65.0 +/- 20.8 0.277
RV EF (%) 45.4 +/- 12.4 46.1 +/- 10.3 0.816
RV End Diastolic Volume Index 
(mL/m2) 88.3 +/- 24.3 84.8 +/- 27.7 0.634
RV End Systolic Volume index 
(mL/m2) 47.6 +/- 22.6 47.1 +/- 22.5 0.927
LA Volume Index (mL/m2) 64.6 +/- 18.7 54.8 +/- 23.9 0.122
Data displayed as n (%) or mean +/- standard deviation. LV = left ventricle. RV = right ventricle. LA = left atrium. ICD = implantable cardioverter defibrillator. Means compared with ANOVA. 
Characteristics and outcomes compared with Pearson’s chi squared testing.
